DIS vs JNJ: Which Is the Better Buy?
Side-by-side comparison of The Walt Disney Company and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-15.
The Walt Disney Company · Communication Services
$96.16
+45.0% upside to fair value
Grade B
VS
Johnson & Johnson · Healthcare
$253.85
-21.7% upside to fair value
Grade D
High Quality
QuantHub Verdict
DIS has more upside to fair value
(+45.0%).
DIS trades at a lower forward P/E
(15.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DIS |
JNJ |
| Current Price |
$96.16 |
$253.85 |
| Fair Value Estimate |
$139.43 |
$198.76 |
| Upside to Fair Value |
+45.0%
|
-21.7%
|
| Market Cap |
$167.0B |
$611.1B |
| Forward P/E |
15.4x
|
29.3x
|
| EV / EBITDA |
10.8x
|
19.2x
|
| Price / Sales |
1.7x
|
6.3x
|
| Price / FCF |
23.5x
|
34.3x
|
| Revenue Growth YoY |
+6.5%
|
+9.9%
|
| Gross Margin |
37.2%
|
69.1%
|
| Operating Margin |
15.5%
|
26.9%
|
| Return on Equity |
10.3%
|
26.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.26%
|
2.91%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
The Walt Disney Company operates as a leading global entertainment and media conglomerate with a strong brand portfolio and diversified revenue streams across media networks, parks, experiences, and studio entertainment. The business quality is medium due to its durable brand and intangible assets but recent earnings pressure with a 31.4% decline in earnings in the most recent quarter highlights …
Johnson & Johnson is a leading healthcare conglomerate operating primarily in the drug manufacturing sector, known for its durable competitive moat supported by strong brand recognition and intangible assets. The company exhibits high business quality with a 26.3% return on equity and robust gross and net margins of 69.1% and 21.8%, respectively. However, earnings have faced significant pressure,…
Accumulation Zones
| Metric |
DIS |
JNJ |
| Zone Low |
$104.57 |
$149.07 |
| Zone High |
$118.52 |
$168.95 |
| In Buy Zone? |
Yes
|
No
|